“Semaglutide May Improve Heart Failure in Obese Patients with Preserved Ejection Fraction: Comment on Journal Study”

https://pubmed.ncbi.nlm.nih.gov/38118037

The abstract does not provide a study, but a comment on a study published in the same journal, suggesting that semaglutide may offer heart failure benefits in obese patients with preserved ejection fraction.